botulinum toxin A

Also found in: Dictionary, Medical.
Related to botulinum toxin A: Botox, Botulinum toxin type a
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for botulinum toxin A

a neurotoxin (trade name Botox) that is used clinically in small quantities to treat strabismus and facial spasms and other neurological disorders characterized by abnormal muscle contractions


Related Words

References in periodicals archive ?
The treatment of major depressive disorder using botulinum toxin A: a 24 week randomized, double-blind, placebo-controlled study.
A pilot evaluating the efficacy of botulinum toxin A in the treatment of Raynaud phenomenon.
Evidence-based medicine: botulinum toxin A in migraine and tension-type headache.
Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).
With the consent of the patient and his family regarding potential risks and benefits, we performed botulinum toxin A (Allergen Pharmaceuticals Ltd., Westport, Ireland) injection into the diaphragm under EMG guidance, including 50 units in the right hemidiaphragm, 25 units in the left hemidiaphragm, and 100 units in each RA [Figure 1].
A total dose of 6.5 units of botulinum toxin A (1.5, two, and three units into three sites from lateral to medial) was injected intramuscularly into the right part of the frontal muscle.
Botulinum toxin a for the treatment of hyperkinetic wrinkle lines.
Botulinum toxin A (1.5-4 units) was injected into Thyroarytenoid muscle bilaterally under EMG guidance.
(3.) Andrew Blitzer, "Botulinum Toxin A and B: A Comparative Dosing Study for Spasmodic Dysphonia," Otolaryngology-Head and Neck Surgery 133, no.
Efficacy of botulinum toxin A for treating idiopathic detrusor overactivity: results from a single center randomized double-blind placebo controlled trial.
Botulinum toxin A has the longest duration of action and is clinically the most important (Andersson, 2013).
Botulinum toxin A has been studied extensively for therapeutic use due to its prolonged effects.
Botulinum toxin A has been established as the first line treatment of choice for BEB.